Stock Events

Stock Events

Wuxi Biologics (Cayman) 

$9.36
67
-$0.30-3.08% 15:10 Today

Statistics

Day High
9.57
Day Low
9.31
52W High
11.21
52W Low
6.76
Volume
4,700
Avg. Volume
80,359
Mkt Cap
56.18B
P/E Ratio
26.65
Dividend Yield
-
Dividend
-

Upcoming

Earnings

26AugExpected
Q1 2021
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Next
0
0.03
0.06
0.09
Expected EPS
0.0868362
Actual EPS
N/A

Financials

22.52%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
3.08BRevenue
693.76MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow WXXWY. It's not an investment recommendation.
Apple
12
AAPL
Microsoft
11
MSFT
NVIDIA
10
NVDA
Alphabet
9
GOOGL

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Sartorius
SARTF
Mkt Cap14.69B
Sartorius Stedim Biotech is a supplier of equipment and services for biopharmaceutical manufacturing, competing in the bioprocessing space with Wuxi Biologics.
Charles River Laboratories International
CRL
Mkt Cap11.24B
Charles River Laboratories offers a broad range of services to support the pharmaceutical and biotech industries, including biologics testing services.
Thermo Fisher Scientific
TMO
Mkt Cap195.86B
Thermo Fisher Scientific provides bioproduction and bioprocessing products and services, competing with Wuxi Biologics in the supply of critical biomanufacturing technologies.
Danaher
DHR
Mkt Cap140.88B
Danaher, through its subsidiaries like Cytiva, competes in the bioprocessing space by providing technologies and services for biomanufacturing.
Bio-Rad Laboratories
BIO
Mkt Cap7.92B
Bio-Rad Laboratories offers products and services in the field of life science research and clinical diagnostics, competing in the biologics tools and services market.
IQVIA
IQV
Mkt Cap34.69B
IQVIA provides advanced analytics, technology solutions, and contract research services to the life sciences industry, competing in the broader biopharmaceutical services market.
Pfizer
PFE
Mkt Cap137.76B
Pfizer, through its contract manufacturing organization Pfizer CentreOne, competes in the biologics manufacturing and development services sector.
Gilead Sciences
GILD
Mkt Cap161.19B
Gilead Sciences, while primarily a biopharmaceutical company, competes for resources, talent, and market share in the biologics sector, particularly in areas of overlapping therapeutic interest.

About

WuXi Biologics (Cayman) Inc. delivers integrated solutions covering the entire lifecycle of biological drug development, from initial discovery to full-scale manufacturing. These services are provided to clients worldwide, with a significant presence in China, North America, and Europe. Beyond its core offerings, the company engages in various specialized activities, including offering expert advice on biopharmaceutical technology, managing international sales agreements, and developing and providing advanced testing solutions. It also handles sales and marketing efforts, supports clinical trials and production of biologics, produces and distributes medical goods, operates a contract development and manufacturing organization (CDMO) for vaccines, and supplies essential materials to the industry. Founded in 2014, WuXi Biologics is based in Wuxi, China, and maintains strategic alliances with partners such as ImmuneOncia Therapeutics, Legochem Biosciences Inc, Worg Pharma, OncoC4, and Exelixis Inc.
Show more...
CEO
Dr. Ge Li Ph.D.
Employees
12575
Country
United States
ISIN
US98260N1081

Listings

MU
DE
1FW.MU
STU
DE
1FW1.STU
STU
DE
1FW2.STU
MU
DE
1FW1.MU

0 Comments

Share your thoughts

FAQ

What is Wuxi Biologics (Cayman) stock price today?▼
The current price of WXXWY is $9.36 USD — it has decreased by -3.08% in the past 24 hours. Watch Wuxi Biologics (Cayman) stock price performance more closely on the chart.
What is Wuxi Biologics (Cayman) stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Wuxi Biologics (Cayman) stocks are traded under the ticker WXXWY.
Is Wuxi Biologics (Cayman) stock price growing?▼
WXXWY stock has fallen by -3.12% compared to the previous week, the month change is a +21.83% rise, over the last year Wuxi Biologics (Cayman) has showed a +37.87% increase.
What is Wuxi Biologics (Cayman) market cap?▼
Today Wuxi Biologics (Cayman) has the market capitalization of 56.18B
When is the next Wuxi Biologics (Cayman) earnings date?▼
Wuxi Biologics (Cayman) is going to release the next earnings report on August 26, 2026.
What is Wuxi Biologics (Cayman) revenue for the last year?▼
Wuxi Biologics (Cayman) revenue for the last year amounts to 3.08B USD.
What is Wuxi Biologics (Cayman) net income for the last year?▼
WXXWY net income for the last year is 693.76M USD.
How many employees does Wuxi Biologics (Cayman) have?▼
As of July 13, 2026, the company has 12,575 employees.
In which sector is Wuxi Biologics (Cayman) located?▼
Wuxi Biologics (Cayman) operates in the Health & Wellness sector.
When did Wuxi Biologics (Cayman) complete a stock split?▼
The last stock split for Wuxi Biologics (Cayman) was on December 10, 2020 with a ratio of 3:1.
Where is Wuxi Biologics (Cayman) headquartered?▼
Wuxi Biologics (Cayman) is headquartered in Wuxi, United States.